If you purchased New Century securities during the Class Period
, you may, no later than April 10, 2007, move to be appointed as a Lead Plaintiff in this class action.
If you have sustained substantial losses in Sunrise securities during the Class Period
, please contact Spector, Roseman & Kodroff, P.
The Complaint alleges that Plaintiff and other Class members were damaged because they purchased stock at artificially inflated prices during the Class Period
as a result of Defendants' fraudulent conduct.
Plaintiff seeks to recover damages on behalf of all purchasers of Par securities during the Class Period
As the above revelations seeped into the market, the Company's stock fell 34% from its Class Period
According to the complaint, the true facts, which were known by the defendants but concealed from the investing public during the Class Period
, were as follows: (a) the Company lacked requisite internal controls, and, as a result, the Company's projections and reported results issued during the Class Period
were based upon defective assumptions and/or manipulated facts; and (b) the Company's financial statements were materially misstated for the first quarter due to the improper classification of warrants as liabilities instead of as equity.
In response to this news, PainCare's stock price dropped by nearly 13% on unusually large trading volume, and the stock price has plunged more than 50% from the stock's high during the Class Period
Plaintiff seeks to recover damages on behalf of all purchasers of NVE common stock during the Class Period
According to the complaint, as a result of defendants' false and misleading Class Period
statements, the Company's shares traded at inflated prices enabling the Company to issue more than $632 million worth of debt during 2003, sell over $480 million worth of warrants and complete numerous stock-for-stock acquisitions using the Company's inflated shares as acquisition currency.
According to the complaint, defendants violated sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5, by issuing a series of material misrepresentations to the market during the Class Period
The complaint alleges that during the Class Period
, defendants made false and misleading statements regarding the Company's business and prospects, including about the capabilities and safety of its primary product, the AngioJet system.